Fetal Physiology Satellite

Wednesday, March 25, 2026

Room: 101

Chairs:
Jennifer Thompson, PhD, University of Calgary
Stephanie Wesolowski, PhD, University of Colorado Anschutz Medical Campus
Kimberley Botting-Lawford, PhD, University College London
Sarah Cilvik, MD, PhD, Wake Forest University

From Bench-to-bedside in Fetal Physiology

SESSION I: The Next Frontier in In Utero Therapeutic Interventions Moderator: Kristin Connor, PhD, Carleton University
8:30 a.m. - 9:30 a.m.	Fetal therapy: state of the art in 2026 Tim Van Mieghem, MD, PhD Mount Sinai Hospital
9:30 a.m. - 10:00 a.m.	COFFEE BREAK
SESSION II: Innovations in Fetal Physiologic Responses Moderators: Kimberley Botting-Lawford, PhD, University College London Rachael Crew, PhD, University of Cambridge
10:00 a.m. - 11:00 a.m.	CamDAS biotechnology: Revolutionising fetal physiology Dino Giussani, PhD ScD FRCOG University of Cambridge
11:00 a.m. - 11:30 a.m.	Next-Generation Tools for Fetal Physiology: Placenta-Specific Gene Targeting Amelia Tanner, PhD University of Colorado Anschutz Medical Campus
11:30 a.m. - 12:00 p.m.	Beyond Size: Placental Factors Underlying Divergent Fetal Responses to Maternal Stress Rebecca Wilson, PhD University of Florida College of Medicine
12:00 p.m. - 1:30 p.m.	LUNCH BREAK
SESSION III: Emerging Therapies for the High-risk Fetus Moderator: Stephanie Wesolowski, PhD, University of Colorado Anschutz Medical Campus Stephane Bourque, PhD, University of Alberta
1:30 p.m. - 2:00 p.m.	Genetic therapies to treat congenital disorders Anna David, PhD FRCOG FMedSci University College London
2:00 p.m. - 2:30 p.m.	Fetal and neonatal hemodynamics as a window into antenatal exposure to a sub-optimal pregnancy Beth Allison, PhD Hudson Institute of Medical Research
2:30 p.m. - 3:00 p.m.	Artificial placenta technology and the extremely preterm fetus: where are we at after nearly 70 years of research? Matt Kemp, PhD National University of Singapore
3:00 p.m. - 3:30 p.m.	Managing Metabolic Disease in Mothers: Mechanisms and Interventions to Improve Fetal Health Owen Vaughan, PhD University College London
3:30 p.m. - 4:00 p.m.	COFFEE BREAK
SESSION IV: Novel Approaches for Fetal Diagnosis Moderators: David Coggin-Carr, MD PhD, University of Vermont Jennifer Thompson, PhD, University of Calgary
4:00 p.m. - 4:30 p.m.	Using omics to identify novel predictors for fetal growth restriction Gordon Smith, MD, PhD University of Cambridge
4:30 p.m. - 5:00 p.m.	Novel approaches to perinatal risk stratification Nathan Blue, MD University of Utah